THC Suppressed Immune Inflammation by Reprogramming Immune Cells Through MicroRNA
THC suppressed an overactive immune response in mice by correcting dysregulated microRNA molecules that control inflammatory T cell development, revealing a precise molecular mechanism for its anti-inflammatory properties.
Quick Facts
What This Study Found
Researchers induced a delayed-type hypersensitivity response in mice (an overactive immune reaction driven by Th1 and Th17 inflammatory T cells) and then treated them with THC. The treatment reduced swelling and immune cell infiltration at the site of inflammation.
THC decreased lymphocyte activation and reduced the development of both Th1 and Th17 inflammatory cell types, including their signature transcription factors and cytokines.
The molecular mechanism involved microRNA (miR), small molecules that regulate gene expression. The immune response caused an overexpression of miR-21 (which promotes Th17 cells) and a decrease in miR-29b (which normally suppresses the inflammatory cytokine interferon-gamma). THC reversed both of these microRNA changes.
When researchers directly manipulated these microRNAs in cells from immunized mice (inhibiting miR-21 or boosting miR-29b), they produced the same effects as THC treatment, confirming the mechanism.
Key Numbers
THC dose: 20 mg/kg. THC reversed miR-21 overexpression and miR-29b downregulation. miR-21 inhibition increased SMAD7 (anti-inflammatory). miR-29b mimicry decreased interferon-gamma expression.
How They Did This
In vivo study using C57BL/6 mice with methylated BSA-induced delayed-type hypersensitivity. THC was administered at 20 mg/kg. Researchers measured swelling, immune cell infiltration, T cell activation, and Th1/Th17 lineage commitment. MicroRNA expression was quantified, and transfection experiments with miR-21 inhibitor and miR-29b mimic confirmed the mechanistic pathway.
Why This Research Matters
This study identifies a precise molecular mechanism for THC's anti-inflammatory effects. Rather than just observing that THC reduces inflammation, it shows exactly how: by correcting the specific microRNA dysregulation that drives inflammatory T cell development. This level of mechanistic understanding could inform development of targeted anti-inflammatory therapies.
The Bigger Picture
Autoimmune and inflammatory conditions affect millions of people, and current treatments often have significant side effects. Understanding exactly how THC modulates the immune response at the microRNA level could lead to more targeted anti-inflammatory drugs that capture cannabis's benefits without psychoactive effects.
What This Study Doesn't Tell Us
Animal study using a single dose of THC in a specific immune challenge model. The microRNA mechanism demonstrated may not apply to all types of inflammation. The 20 mg/kg dose is relatively high and may not reflect typical human exposure. Translation to human autoimmune conditions requires further research.
Questions This Raises
- ?Do other cannabinoids (CBD, CBG) affect the same microRNA pathways?
- ?Would lower doses of THC produce the same microRNA corrections?
- ?Could synthetic miR-21 inhibitors or miR-29b mimics be developed as anti-inflammatory drugs inspired by this mechanism?
- ?Does chronic cannabis use alter baseline microRNA profiles in the immune system?
Trust & Context
- Key Stat:
- THC corrected two specific microRNA dysregulations driving inflammatory T cell activation.
- Evidence Grade:
- Preliminary evidence from a well-designed animal study with mechanistic confirmation through transfection experiments, though human relevance remains to be established.
- Study Age:
- Published in 2016. MicroRNA-mediated immunomodulation is a growing area of both cannabis and immunology research.
- Original Title:
- Marijuana-derived Δ-9-tetrahydrocannabinol suppresses Th1/Th17 cell-mediated delayed-type hypersensitivity through microRNA regulation.
- Published In:
- Journal of molecular medicine (Berlin, Germany), 94(9), 1039-51 (2016)
- Authors:
- Sido, Jessica M(2), Jackson, Austin R, Nagarkatti, Prakash S(5), Nagarkatti, Mitzi
- Database ID:
- RTHC-01267
Evidence Hierarchy
Tests effects in animals (usually mice or rats), not humans.
What do these levels mean? →Frequently Asked Questions
How does THC reduce inflammation?
This study shows THC works by correcting small regulatory molecules called microRNAs that control immune cell development. Specifically, it reversed the overproduction of miR-21 (which drives inflammation) and restored miR-29b (which restrains it), shifting the balance away from inflammatory T cells.
Could this lead to new anti-inflammatory drugs?
Potentially. Understanding the exact molecular targets through which THC modulates immunity could enable development of drugs that hit these same microRNA pathways without the psychoactive effects of THC.
Read More on RethinkTHC
- CBD-oil-quality-guide
- anxiety-medication-after-quitting-weed
- cannabis-chemotherapy-nausea
- cannabis-chronic-pain-research
- cannabis-epilepsy-CBD-Epidiolex
- cbd-anxiety-research-evidence
- cbd-for-weed-withdrawal
- cbd-vs-thc-difference
- medical-benefits-of-cannabis
- quitting-weed-before-surgery
- quitting-weed-medication-interactions
- quitting-weed-pregnancy
- quitting-weed-pregnant
- seniors-older-adults-cannabis-risks-medications
- weed-breastfeeding-THC-breast-milk
Cite This Study
https://rethinkthc.com/research/RTHC-01267APA
Sido, Jessica M; Jackson, Austin R; Nagarkatti, Prakash S; Nagarkatti, Mitzi. (2016). Marijuana-derived Δ-9-tetrahydrocannabinol suppresses Th1/Th17 cell-mediated delayed-type hypersensitivity through microRNA regulation.. Journal of molecular medicine (Berlin, Germany), 94(9), 1039-51. https://doi.org/10.1007/s00109-016-1404-5
MLA
Sido, Jessica M, et al. "Marijuana-derived Δ-9-tetrahydrocannabinol suppresses Th1/Th17 cell-mediated delayed-type hypersensitivity through microRNA regulation.." Journal of molecular medicine (Berlin, 2016. https://doi.org/10.1007/s00109-016-1404-5
RethinkTHC
RethinkTHC Research Database. "Marijuana-derived Δ-9-tetrahydrocannabinol suppresses Th1/Th..." RTHC-01267. Retrieved from https://rethinkthc.com/research/sido-2016-marijuanaderived-9tetrahydrocannabinol-suppresses-th1th17
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.